Furthermore, we showed that inhibition of MAP3K1 significantly reduced cell growth and migration and NF-κB-dependent genes; it also enhanced the cytotoxicity of tamoxifen in two ER-positive IDC cell lines (MCF-7 and T-47D, to mimic DCIS) [31]. The gene discussed is MAP3K1; the disease is ductal breast carcinoma in situ.